DocuSign (NASDAQ:DOCU – Get Rating) had its price objective decreased by UBS Group from $52.00 to $45.00 in a research note issued to investors on Wednesday morning, The Fly reports. Several other equities analysts have also recently weighed in on the company. Citigroup lifted their price target on DocuSign from $72.00 to $82.00 and gave […]